Famotidine
NDC 69238-2090, Famotidine, powder, for suspension, from Amneal Pharmaceuticals NY LLC.
- Product NDC
- 69238-2090
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals NY LLC
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216427
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69238-2090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69238-2090-4 | 69238209004 | 50 mL in 1 BOTTLE (69238-2090-4) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/bb602b05-0ce6-4029-bd6e-291076e64efbNADAC price for package 69238209004
GET /v1/drugs/nadac/69238209004
Use it
Look up 69238-2090 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69238-2090 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69238-2090. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.